A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens.

Imagen de Sharilyn Almodovar
PDF versionPDF version
TítuloA new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens.
Publication TypeJournal Article
Year of Publication2006
AutoresContreras-Galindo, R, González, M, Almodóvar, S, González-Ramírez, S, Lorenzo, E, Yamamura, Y
JournalJ Virol Methods
Volume136
Issue1-2
Pagination51-7
Date Published2006 Sep
ISSN0166-0934
Palabras claveAnalysis of Variance, Antiretroviral Therapy, Highly Active, Base Sequence, Cloning, Molecular, Endogenous Retroviruses, Fluorescence, HIV Infections, HIV-1, Humans, Molecular Sequence Data, Organic Chemicals, Reproducibility of Results, Reverse Transcriptase Polymerase Chain Reaction, RNA, Viral, Sensitivity and Specificity, Staining and Labeling, Viral Load
Abstract

Viral components of the human endogenous retroviruses type K (HERV-K) have been largely detected in plasma from HIV-1 infected individuals. A Sybr Green Real-Time RT-PCR approach was optimized for detection and quantitation of HERV-K RNA titers in plasma samples using the iCycler technology. The method detected 1000 HERV-K RNA copies/mL of plasma sample. The Intra- and Inter-assay performance revealed a coefficient of variations that ranged from 0.2 to 2.46%, demonstrating accuracy and reproducibility. We quantified the HERV-K RNA load in 20 HIV-1 patients receiving highly active antiretroviral therapy (HAART). We found increased HERV-K RNA titers in patients with non-suppressive HAART (patients who may develop drug-resistance and/or received suboptimal therapeutic doses), compared to suppressive regimens (p < 0.001). HERV-K RNA was not detected in HCV-1 positive or seronegative controls. Sequencing of Real-Time RT-PCR products revealed particular HERV-K subtypes activated in the HIV-1 infection. The application of this assay could expand the understanding of the role of HERV-K in the HIV-1 infection and others pathological conditions.

DOI10.1016/j.jviromet.2006.03.029
Alternate JournalJ. Virol. Methods
PubMed ID16678919